Additionally, there were significant correlations between high GOLT1B expression and poor disease-free survival (DFS) for TCGA cases of BLCA, GBM, MESO, PAAD, and SARC (Figure 2B). This evidence concerns the gene GOLT1B and bladder transitional cell carcinoma.